InMode (INMD) Cash from Operations Growth (5y) (2023 - 2026)
InMode (INMD) Cash from Operations Growth (5y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.44 Bn | 175.14 Bn | 6.27 Bn |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn |
| 3 | Medtronic | 108.67 Bn | 99.45 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn |
| 6 | Dexcom | 28.59 Bn | 27.48 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.53 Bn | 26.24 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.30 Bn | 2.07 Bn |
| 10 | InMode | 975,424.40 | -479.15 Mn | 61.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.08% |
| Dec 31, 2025 | -11.42% |
| Sep 30, 2025 | -4.12% |
| Jun 30, 2025 | 78.62% |
| Mar 31, 2025 | 18.07% |
| Dec 31, 2024 | 3.42% |
| Sep 30, 2024 | 20.30% |
| Jun 30, 2024 | 17.85% |
| Mar 31, 2024 | 54.14% |
| Dec 31, 2023 | 45.25% |
| Sep 30, 2023 | 41.81% |
| Jun 30, 2023 | 32.86% |